KORU Medical Systems, Inc. (NASDAQ:KRMD) Given Average Rating of “Moderate Buy” by Analysts

KORU Medical Systems, Inc. (NASDAQ:KRMD) has been assigned an average recommendation of “Moderate Buy” from the six research firms that are currently covering the stock, Marketbeat Ratings reports. One analyst has rated the stock with a sell rating, one has given a hold rating, three have assigned a buy rating and one has assigned a strong buy rating to the company. The average 12 month price target among brokers that have covered the stock in the last year is $6.1250.

A number of equities research analysts have recently commented on KRMD shares. Wall Street Zen raised shares of KORU Medical Systems from a “buy” rating to a “strong-buy” rating in a research note on Monday, January 12th. Canaccord Genuity Group boosted their target price on shares of KORU Medical Systems from $5.00 to $6.00 and gave the company a “buy” rating in a report on Wednesday, December 17th. Lake Street Capital upped their price target on shares of KORU Medical Systems from $6.00 to $8.00 and gave the company a “buy” rating in a research report on Monday, December 22nd. Craig Hallum reissued a “buy” rating and issued a $7.00 price objective on shares of KORU Medical Systems in a research report on Tuesday, January 13th. Finally, Weiss Ratings reissued a “sell (d-)” rating on shares of KORU Medical Systems in a research note on Thursday, January 22nd.

Hedge Funds Weigh In On KORU Medical Systems

A number of institutional investors and hedge funds have recently modified their holdings of the business. Police & Firemen s Retirement System of New Jersey acquired a new position in shares of KORU Medical Systems during the second quarter valued at about $30,000. BNP Paribas Financial Markets lifted its position in KORU Medical Systems by 52.1% in the 3rd quarter. BNP Paribas Financial Markets now owns 10,148 shares of the company’s stock valued at $39,000 after acquiring an additional 3,478 shares in the last quarter. Lazard Asset Management LLC bought a new position in KORU Medical Systems in the 2nd quarter valued at about $59,000. Acadian Asset Management LLC acquired a new position in KORU Medical Systems during the 1st quarter valued at about $63,000. Finally, Intech Investment Management LLC bought a new stake in KORU Medical Systems during the 2nd quarter worth approximately $73,000. 58.60% of the stock is currently owned by institutional investors.

KORU Medical Systems Trading Down 0.7%

KRMD stock traded down $0.04 during trading on Monday, hitting $4.74. The company had a trading volume of 37,773 shares, compared to its average volume of 205,024. The stock has a market cap of $219.33 million, a PE ratio of -59.21 and a beta of 0.47. The business has a 50-day moving average of $5.40 and a 200-day moving average of $4.77. The company has a current ratio of 2.48, a quick ratio of 1.92 and a debt-to-equity ratio of 0.01. KORU Medical Systems has a one year low of $1.86 and a one year high of $6.61.

KORU Medical Systems Company Profile

KORU Medical Systems, Inc develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria. Its products include the FREEDOM60 syringe infusion system, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing products.